PDCD1 and neoplasm: Such “critical mass” of immune cells, which includes T cells that recognize the endogenous p15E tumor antigen, possibly other neo-antigens as well as NK cells, provides a more robust immunogenic tumor microenvironment that allows the interruption of the PD-1/PD-L1 axis to sustain a more potent antitumor response leading to complete tumor regression.